Dr. Martin Pomper, MD

• Diagnostic Radiology

• Nuclear Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• The Johns Hopkins Hospital

  Fellowship Hospital, 1996

• The Johns Hopkins Hospital

  Residency Hospital, 1995

• The Johns Hopkins Hospital

  Internship Hospital, 1991

• University Of Illinois College Of Medicine

  Medical School, 1990

• Novel functional renal PET imaging with18F-FDS in human subjects, 2019-01-08

• Tumor-Specific Expression and Detection of a CEST Reporter Gene, 2015-04-27

• Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer, 2019-12-16

• ImagingEnterobacteralesinfections in patients using pathogen-specific positron emission tomography, 2021-04-14

• Standardized Radiomics Analysis of Clinical Myocardial Perfusion Stress SPECT Images to Identify Coronary Artery Calcification, 2023-08-11

• Translational Molecular Imaging of Prostate Cancer, 2013-07-17

• A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS), 2020-06-01

• Transneuronal Propagation of Pathologic a-Synuclein from the Gut to the Brain Models Parkinson's disease, 2019-06-26

• Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter forMycobacterium tuberculosisin Live Animals, 2009-07-16

• Synthesis and Preliminary Evaluation of211At-labeled Inhibitors of Prostate-Specific Membrane Antigen for Targeted Alpha Particle Therapy of Prostate Cancer, 2021-01-23

• Molecular Imaging of Inflammation in the ApoE -/- Mouse Model of Atherosclerosis with IodoDPA, 2015-04-06

• Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression, 2013-01-16

• A comparison of prostate cancer bone metastases on18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion, 2018-12-28

• Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection, 2020-09-17

• Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters, 2023-08-15

• Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances, 2018-02-03

• Cannabinoid CB2 Receptors in a Mouse Model of Aß Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation, 2015-06-18

• Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted18F-DCFPyL PET/CT, 2015-08-19

• Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow, 2022-11-15

• Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection, 2020-11-17

• A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects, 2022-02-07

• Development and application of a novel model system to study ‘active' and ‘passive' tumor targeting, 2016-08-02

• Computed Tomography Appearance of Renal Hybrid Oncocytic/Chromophobe Tumors, 2016-06-02

• Developing imidazoles as CEST MRI pH sensors, 2016-04-13

• CRYßB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer, 2021-08-02

• Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications, 2018-08-14

• Generation of Digital Brain Phantom for Machine Learning Application of Dopamine Transporter Radionuclide Imaging, 2022-08-12

• Ultrahigh affinity Raman probe for targeted live cell imaging of prostate cancer† †Electronic supplementary information (ESI) available: Fig. S1-S7. See DOI: 10.1039/c6sc01739h Click here for additional data file., 2016-07-15

• Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage, 2015-06-01

• Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery, 2021-06-23

• In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [125I]Iodo-ASEM and [18F]ASEM as Radiotracers of Homo- and Heteromeric a7 Nicotinic Acetylcholine Receptors, 2020-03-20

• Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET, 2022-12-29

• CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas, 2021-03-29

• Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors, 2021-01-19

• Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer, 2020-04-06

• Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT, 2019-07-19

• High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with18F-DCFPyL, 2022-02-23

• Uptake of18F-DCFPyL in Paget's Disease of Bone, an Important Potential Pitfall in Clinical Interpretation of PSMA PET Studies, 2016-01-06

• Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease, 2021-04-26

• 177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy, 2019-08-10

• Anthranilic acid analogues as diamagnetic CEST (diaCEST) MRI contrast agents that feature an IntraMolecular-bond Shifted HYdrogen (IM-SHY), 2014-04-28

• The Number of Frames on ECG-Gated18F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional Parameters, 2021-12-06

• CXCR4-Directed Imaging in Solid Tumors, 2019-08-14

• Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer, 2020-02-03

• Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas, 2018-01-30

• The prostate-specific membrane antigen (PSMA)-targeted radiotracer18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer, 2020-10-09

• PSMA-Targeted18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy, 2016-06-28

• Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma, 2019-03-08

• Theranostics in Oncology-Thriving, Now More than Ever, 2021-04-29

• GlucoCEST-based dynamic glucose enhanced (DGE) MRI at 3 T: Early experience in healthy volunteers and brain tumor patients, 2019-12-24

• Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT, 2007-10-10

• Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity A Translational Approach, 2018-09-18

• The next era of renal radionuclide imaging: novel PET radiotracers, 2019-05-30

• Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer, 2018-04-26

• State-of-the-Art in Design Rules for Drug Delivery Platforms: Lessons from FDA-approved Nanomedicines, 2014-05-27

• Metabolic signatures imaged in cancer-induced cachexia, 2011-09-26

• Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake, 2021-02-26

• A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE), 2017-06-29

• A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia, 2020-10-19

• PET imaging of soluble epoxide hydrolase in non-human primate brain with [18F]FNDP, 2020-06-22

• Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer, 2020-03-26

• Clinical impact of PSMA-based18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy, 2017-09-11

• Tuning phenols with Intra-Molecular bond Shifted HYdrogens as diaCEST MRI contrast agents, 2014-10-10

• 3T MR Spectroscopy Reveals an Imbalance between Excitatory and Inhibitory Neurotransmitters in Amyotrophic Lateral Sclerosis, 2015-03-13

• Characterization of a Novel Metastatic Prostate Cancer Cell Line of LNCaP Origin, 2015-10-26

• Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on18F-DCFPyL PET/CT Scans, 2022-10-27

• Molecular Imaging in Oncology: Current Impact and Future Directions, 2021-12-13

• High-potency ligands for DREADD imaging and activation in rodents and monkeys, 2019-10-11

• [64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma, 2016-07-14

• Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT, 2022-01-06

• Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1a in Triple Negative Breast Cancer, 2012-08-28

• Molecular Imaging-Derived Biomarker of Cardiac Nerve Integrity - Introducing High NET Affinity PET Probe18F-AF78, 2022-05-24

• Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality, 2018-08-23

• [68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas, 2019-06-12

• Diagnostic Accuracy Using Diffusion Tensor Imaging in the Diagnosis of ALS:A Meta-analysis, 2012-06-28

• PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies, 2017-11-11

• A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer, 2019-07-30

• OPTIMIZATION OF PEPTIDE-BASED INHIBITORS OF PROSTATE-SPECIFIC ANTIGEN (PSA) AS TARGETED IMAGING AGENTS FOR PROSTATE CANCER, 2009-06-13

• Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells, 2016-03-03

• Hereditary spherocytosis presenting as diffuse bone marrow activation and splenomegaly on PSMA-targeted18F-DCFPyL PET/CT, 2019-01-03

• Evaluation of Prostate-Specific Membrane Antigen as an Imaging Reporter, 2014-04-03

• Low Levels of PSMA Expression Limit the Utility of18F-DCFPyL PET/CT for Imaging Urothelial Carcinoma, 2017-10-24

• Meeting Report from the Prostate Cancer Foundation PSMA Theranostics State of the Science Meeting, 2020-08-31

• PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy, 2012-08-09

• High-Throughput Screen Identifies Novel Inhibitors of Cancer Biomarker a-Methylacyl Coenzyme A Racemase (AMACR/P504S), 2011-03-25

• PSMA-Based Detection of Prostate Cancer Bone Lesions with18F-DCFPyL PET/CT: A Sensitive Alternative to99mTc-MDP Bone Scan and Na18F PET/CT?, 2015-09-30

• Opportunities in precision psychiatry using PET neuroimaging in psychosis, 2019-03-20

• Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles, 2019-09-10

• A three-stage, deep learning, ensemble approach for prognosis in patients with Parkinson's disease, 2021-06-07

• Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T, 2022-01-27

• First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients, 2022-04-01

• The SARS-CoV-2 spike protein binds and modulates estrogen receptors, 2022-05-23

• Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma, 2022-07-01

• Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted18F-DCFPyL in peripheral ganglia, 2017-08-22

• A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer, 2021-04-08

• Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET, 2018-12-19

• Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy, 2020-08-17

• Phenols as DiamagneticT2-Exchange Magnetic Resonance Imaging Contrast Agents, 2018-01-11

• Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer, 2021-04-07

• Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate Cancer, 2014-12-12

• A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging, 2021-09-15

• Prospective Evaluation of18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI, 2020-07-08

• Imaging of carbonic anhydrase IX with an111In-labeled dual-motif inhibitor, 2015-09-16

• Imaging Enterobacteriaceae infection in vivo with18F-fluorodeoxysorbitol positron emission tomography, 2014-10-22

• Process validation, cGMP production, dosimetry, and toxicity studies of the CAIX imaging agent [111In]XYIMSR-01 for phase I regulatory approval, 2021-03-04

• Salicylic Acid and Analogs: Diamagnetic Chemical Exchange Saturation Transfer (diaCEST) Magnetic Resonance Imaging (MRI) Contrast Agents with Highly Shifted Exchangeable Protons**, 2013-06-21

• Decreased microglial activation in MS patients treated with glatiramer acetate, 2011-12-09

• Theranostic imaging of cancer, 2014-06-04

• PSMA-Specific Theranostic Nanoplex for Combination of TRAIL Gene and 5-FC Prodrug Therapy of Prostate Cancer, 2015-12-02

• Biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino esters), 2013-04-05

• Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake, 2020-12-23

• The effect of ApoE e4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study, 2019-03-28

• 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging, 2020-01-01

• Synthesis of [125I]IodoDPA-713, a New Probe for Imaging Inflammation, 2009-08-22

• Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules, 2021-03-17

• Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon, 2021-04-07